SHARE
COPY LINK

COVID-19 VACCINES

EU and AstraZeneca both claim victory after Covid vaccine judgement

Both Astra Zeneca and the EU claimed victory on Friday after the first court case linked to the row over the delivery of Covid vaccine doses.

People wait to be allowed to leave a centre after receiving their vaccination against coronavirus
ANDER GILLENEA / AFP

The Anglo-Swedish company said the EU had lost a legal case against it, but European Commission President Ursula von der Leyen said the court ruling supported its view that the medical firm had failed to honour its commitments, reported Reuters.

AstraZeneca had committed to do its best to deliver 300 million doses to the 27-nation bloc by the end of June, but production delays led it to revise this to 100 million vaccines, delaying the bloc’s vaccine roll out.

COMPARE: What are the Covid test requirements around Europe for child travellers

This sparked a bitter row and the EU took legal action to secure at least 120 million doses by the end of June.

However, the judge ruled that AstraZeneca must deliver only 80.2 million doses by a deadline of September 27th. The drugmaker said it would “substantially exceed” that by the end of June. 

AstraZeneca must now deliver 15 million doses by July 26th, another 20 million by August 23rd and a further 15 million by September 27th, to reach a total of 50 million doses.

A pharmacist prepares a dose of the AstraZeneca/Oxford Covid-19. (Photo by LOIC VENANCE / AFP)

This is in addition to the 30 million that had been given to the EU when the legal case began, a court statement read.

Failure to do so would result in a penalty of “10 euros per dose not delivered”, the judge said.

EU data shows the company has already dispatched nearly 70 million doses, more than half of which were delivered after the start of the legal proceedings, the news agency reported.

This brings AstraZeneca close to already meeting the court’s requirement of 80 million doses in total by September 27th.

READ ALSO: Europe remains at risk of Autumn Covid resurgence, WHO warns

An EU lawyer also said the judgment meant that as a proof of best effort, AstraZeneca will have to deliver Covid-19 vaccines from a factory in Britain, if needed, to meet its EU commitments.

The company had said it could not immediately deliver to the EU doses from an Oxford BioMedica factory because it had to supply Britain first.

The ruling said that AstraZeneca may have committed a serious breach of the contract by reserving Oxford BioMedica’s output for the British market. A final decision on this will be made in a second legal case.

In a statement, the company said, “The judgement also acknowledged that the difficulties experienced by AstraZeneca in this unprecedented situation had a substantial impact on the delay.

“AstraZeneca now looks forward to renewed collaboration with the European Commission to help combat the pandemic in Europe.”

The case of speeding up delivery is one of the legal challenges being brought by the EU against the drugmaker. A second legal action by the EU over an alleged breach of the supply contract by AstraZeneca will continue after the summer.

Member comments

  1. So, the EU wanted 230million doses delivered by the end of September and the Court ordered just 10million. No fine was imposed and the Court determined that the EU had no exclusivity or priority of supply. Difficult to see how VDL can claim this as a win since it turns out that buying vaccines really is like buying meat in a butcher’s shop and EU is at the back of the queue.

  2. Agree all of this just confirms the EU,s outrageous arrogance. I thought they wanted AZ banned anyway??? They have done all they can to destroy its reputation.

    1. I quite agree the EU has and still is acting shamelessly – Kim Jong-un could learn a thing or two from these!

  3. While the EU and the US pharma companies are making billions of euros and dollars in profiteering from the pandemic together with their governments in taxes , the UK based AZ is being castigated and sued by the EU for its best efforts to deliver a vaccine at cost to the world.
    Shame on the EU for not addressing the greed of their pharma companies and instead targetting AZ and destroying the reputation of its vaccine, a vaccine the world needs because it can afford it.

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19 RULES

Denmark to offer all over-50s autumn Covid-19 vaccine

As many as 2.5 million residents of Denmark, almost half the country’s population, will be offered an new booster vaccination against Covid-19 this autumn.

Denmark to offer all over-50s autumn Covid-19 vaccine

Prime Minister Mette Frederiksen presented on Wednesday the national plan for a potential new wave of the coronavirus this autumn and winter.

At a press briefing, Frederiksen said that nursing and care home residents, as well as everyone over the age of 50, would be offered Covid-19 vaccination this autumn.

People who live in care homes and others in vulnerable groups will be offered the vaccine from September 15th, with over-50s invited to be vaccinated from October 1st.

A new round of vaccination is part of a broader strategy to avoid shutting down parts of society due to national Covid-19 outbreaks, as seen in Denmark and the rest of the world in 2020 and 2021.

She said that vaccines were to thank for restrictions in winter 2021-22 being less severe than in the preceding year.

“The most important tool is still the vaccines. They showed their value last winter,” she said.

“But we also know that the protection given by vaccines fall off over time and that health authorities expect a new (Covid-19) wave,” she said.

READ ALSO: Covid-19: Omicron subvariant now dominant in Denmark

The director of the Danish Health Authority, Søren Brostrøm, said at the briefing that the decision to offer vaccination to over-50s was based on a “principle of caution”.

The World Health Authority has recommended offering vaccination to people over 60, Brostrøm said.

Danish residents under the age of 50 will be offered a vaccine if they are vulnerable or in risk groups for serious illness with Covid-19.

The vaccines from Moderna and Pfizer will be used in the Danish vaccination programme, as was the case in 2021.

Existing Covid-19 vaccines are known not to protect with high effectiveness against infection with the Omicron variant, but do reduce the severity of illness if it is contracted.

“One of the things we have learned with the new variants Omicron, ed.] is that the vaccines are not particularly good at preventing infection. We’ve learned something here,” Brostrøm said.

But their ability to reduce the severity of disease means that, by vaccinating a large part of the population, Denmark can avoid a “large wave of illness,” he said.

SHOW COMMENTS